Tomislav Majic
Senior physician and Head of the Psychotropic Substances Research Group at Charité – Universitätsmedizin Berlin
Data updated
Research Footprint
Tomislav Majic appears in 10 tracked papers (2015–2026), most studied alongside Psilocybin, LSD and Placebo, across Depressive Disorders, Safety & Risk Management and Anxiety Disorders.
Most-cited paper: Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences (267 citations).
Frequent co-authors: Henrik Jungaberle, Lea Mertens and Gerhard Gründer.
Background & Research
Tomislav Majić studied medicine and philosophy at Freie Universität Berlin and Humboldt Universität zu Berlin, and has worked at the Psychiatric University Clinic at St. Hedwig Hospital since 2006. He founded the Psychotropic Substances working group in 2015 and serves as a consultant doctor for a day clinic/outpatient clinic focused on dual diagnosis and psychoactive substances. His work has included research and clinical attention to psychedelic-related harms and therapeutic applications.
Key Impact
He is a psychiatrist and psychedelics researcher at Charité who has helped lead clinical and observational work on serotonergic psychedelics and related substances, including their therapeutic potential and risks.
Collaboration Network
24 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Tomislav Majic is associated with.